Home
Conditions
Lymphocytic Leukemia

Clinical trial condition

Lymphocytic Leukemia

Explore clinical trials studying Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

11 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Lymphocytic Leukemia trial results

Recruiting

Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

NCT07566364

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Recruiting

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

NCT03219450

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy

NCT05065866

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Symbenda Post-Marketing Surveillance (PMS)

NCT02434484

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations: Eisai Trial Site #7 Busan, South Korea

Eisai Trial Site #8 Busan, South Korea

Eisai Trial Site #6 Daegu, South Korea

Eisai Trial Site #4 Daejeon, South Korea

View Trial Details

Completed

Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients

NCT02481297

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

NCT00013533

Conditions: ALL, AML, Bone Marrow Diseases, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02556892

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Fukuoka, Japan

Hiroshima, Japan

Isehara, Japan

Kobe, Japan

View Trial Details

Completed

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

NCT01499147

Conditions: Acute Leukemia, Acute Myeloid Leukemia, Anemia, +51 more
Locations: University of Illinois at Chicago Medical Center Chicago, Illinois, United States

View Trial Details

Completed

Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies

NCT02885038

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Not specified

View Trial Details

Completed

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00935792

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +10 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Lymphocytic Leukemia

Lymphocytic Leukemia trial results

Related conditions